跳至主要内容
临床试验/CTRI/2022/12/048297
CTRI/2022/12/048297尚未招募未知

Adverse effect profile of antipsychotic monopharmacy vs antipsychotic polypharmacy in patients with Schizophrenia.

Department of psychiatry0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • ï?±Patients meeting diagnostic criteria of Schizophrenia according to ICD 11.
  • ï?±Patients of age 18 or above
  • ï?±Patients on nicotine and caffeine.
  • ï?±On stable antipsychotic dose for more than 2 weeks.
  • ï?±Patients/legally acceptable representatives willing to give written informed consent for participating in the study

排除标准

  • ï?±Symptoms are a manifestation of another health condition(eg organic like brain tumour)
  • ï?±Symptoms are a manifestation of drug intoxication or withdrawal including Substance Dependence (eg alcohol) (Nicotine and caffeine users included in the study)
  • ï?±Pregnancy and postpartum period.
  • ï?±Patients on clozapine.
  • ï?±Patients on any other class of drugs except Benzodiazepines and antiparkinsonian drugs.

研究者

相似试验